14-day Premium Trial Subscription Try For FreeTry Free
$38.20
+0.95 (+2.55%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $32.03 $45.00 Thursday, 2nd May 2024 CRBP stock ended at $38.20. This is 2.55% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.03% from a day low at $37.84 to a day high of $39.37.
90 days $20.23 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Dec 09, 2021 $24.90 $25.38 $24.09 $24.23 18 895
Dec 08, 2021 $24.00 $25.95 $22.80 $24.60 21 642
Dec 07, 2021 $22.92 $24.00 $22.51 $23.66 23 316
Dec 06, 2021 $21.60 $23.01 $21.03 $22.42 31 451
Dec 03, 2021 $24.89 $24.89 $21.00 $22.20 49 910
Dec 02, 2021 $24.30 $25.32 $23.10 $24.67 35 489
Dec 01, 2021 $26.10 $26.42 $24.00 $24.02 27 129
Nov 30, 2021 $25.65 $26.96 $25.20 $25.91 24 661
Nov 29, 2021 $26.40 $26.52 $25.55 $25.55 20 282
Nov 26, 2021 $27.00 $27.00 $25.55 $26.52 11 871
Nov 24, 2021 $26.31 $27.75 $25.54 $27.36 25 024
Nov 23, 2021 $26.41 $27.00 $25.50 $26.39 37 415
Nov 22, 2021 $27.97 $28.25 $26.37 $26.54 45 862
Nov 19, 2021 $27.83 $29.40 $26.10 $27.97 50 422
Nov 18, 2021 $30.30 $30.90 $27.30 $27.60 80 412
Nov 17, 2021 $31.50 $31.80 $30.30 $30.30 40 021
Nov 16, 2021 $33.30 $33.30 $32.10 $32.10 21 165
Nov 15, 2021 $32.70 $33.30 $31.80 $33.30 39 332
Nov 12, 2021 $31.50 $33.00 $30.90 $31.80 75 518
Nov 11, 2021 $30.30 $31.50 $29.70 $31.50 45 325
Nov 10, 2021 $31.20 $31.20 $30.00 $30.00 32 292
Nov 09, 2021 $32.10 $32.70 $31.20 $31.20 23 642
Nov 08, 2021 $31.20 $33.00 $30.90 $32.70 74 959
Nov 05, 2021 $30.90 $31.80 $30.30 $30.90 27 752
Nov 04, 2021 $31.20 $31.80 $30.75 $30.90 27 573
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT